Print

Eidogen-Sertanty, Inc. Licenses Kinase Database To Medisyn Technologies, Inc.  
10/19/2005 5:09:14 PM

SAN DIEGO--(BUSINESS WIRE)--Sept. 7, 2005--Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, today announced that they have licensed their Kinase Knowledgebase(TM) to Medisyn Technologies, a Minnesota-based early-stage drug discovery company. This announcement comes after the significant expansion of the Eidogen Kinase Knowledgebase in July 2005, which now contains over 160,000 SAR data points and over 390,000 unique kinase compounds mined from scientific literature and patents. The Kinase Knowledgebase is Eidogen-Sertanty's database of structure-activity relationships (SAR) and chemical synthesis data focused on protein kinases -- one of the most therapeutically important classes of drug targets.
//-->